PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia | MicrobiomeTrials← Back to trialsNCT06033131
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2024-01-19Est. Completion: 2027-12-31
Enrollment target: 294 participants Locations- Helsinki University Hospital, Helsinki, Finland
- Tampere University Hospital, Tampere, Finland
- Akershus University Hospital, Lørenskog, Norway
- Oslo University Hospital, Oslo, Norway
- Södra Älvsborgs Hospital, Borås, Sweden
- Falu Lasarett, Falun, Sweden
- Sahlgrenska University Hospital, Gothenburg, Sweden
- Linköping University Hospital, Linköping, Sweden
- Skåne University Hospital, Lund, Sweden
- Skåne University Hospital, Malmö, Sweden
- Karolinska University Hospital Huddinge, Stockholm, Sweden
- Karolinska University Hospital Solna, Stockholm, Sweden
- Danderyd Hospital, Stockholm, Sweden
- Norra Älvsborgs County Hospital, Trollhättan, Sweden
- Norrland´s University Hospital, Umeå, Sweden
- Uppsala University Hospital, Uppsala, Sweden
- Västmanlands Hospital Västerås, Västerås, Sweden
Other microbiome trials you might be interested in
Diabetes MellitusPregnancy Complications
A randomized controlled trial evaluating whether a patient-centered virtual educational tool based on small videos focus…
Copenhagen, DenmarkCompleted Jun 1, 2026
Infertility, Female
The goal of the PROMISE study is to determine how pre-conception lifestyle factors (e.g., sleep, nutrition, physical act…
Chicago, United StatesEst. completion Dec 2046